402 related articles for article (PubMed ID: 24929000)
1. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
[TBL] [Abstract][Full Text] [Related]
2. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
[TBL] [Abstract][Full Text] [Related]
3. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.
Gross AJ; Lyandres JR; Panigrahi AK; Prak ET; DeFranco AL
J Immunol; 2009 May; 182(9):5382-92. PubMed ID: 19380785
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
5. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
[TBL] [Abstract][Full Text] [Related]
6. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
Chan VW; Lowell CA; DeFranco AL
Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
[TBL] [Abstract][Full Text] [Related]
7. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
[TBL] [Abstract][Full Text] [Related]
8. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
[TBL] [Abstract][Full Text] [Related]
9. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
Craxton A; Jiang A; Kurosaki T; Clark EA
J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450
[TBL] [Abstract][Full Text] [Related]
10. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
11. Signaling mutations and autoimmunity.
Yu CC; Mamchak AA; DeFranco AL
Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
[TBL] [Abstract][Full Text] [Related]
12. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
Cornall RJ; Goodnow CC; Cyster JG
Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
[No Abstract] [Full Text] [Related]
14. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
15. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.
Wu HJ; Bondada S
J Clin Immunol; 2009 Jan; 29(1):12-21. PubMed ID: 19067131
[TBL] [Abstract][Full Text] [Related]
16. IgA-producing plasma cells originate from germinal centers that are induced by B-cell receptor engagement in humans.
Barone F; Vossenkamper A; Boursier L; Su W; Watson A; John S; Dunn-Walters DK; Fields P; Wijetilleka S; Edgeworth JD; Spencer J
Gastroenterology; 2011 Mar; 140(3):947-56. PubMed ID: 21147106
[TBL] [Abstract][Full Text] [Related]
17. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
18. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
19. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]